Business Description
Sesen Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US8177631053
Compare
Compare
Traded in other countries / regions
PCBK.Germany IPO Date
2016-04-22Description
Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -10.51 | |||||
| 12-1 Month Momentum % | 3.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 61.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sesen Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 40.4 | ||
| EPS (TTM) (€) | -1.835 | ||
| Beta | 0 | ||
| Volatility % | 108.78 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.504714 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 3.39 | ||
| 52-Week Range (€) | 6.88 - 18.188 | ||
| Shares Outstanding (Mil) | 10.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sesen Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sesen Bio Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sesen Bio Inc Frequently Asked Questions
What is Sesen Bio Inc(FRA:PCBK)'s stock price today?
The current price of FRA:PCBK is €10.25. The 52 week high of FRA:PCBK is €18.19 and 52 week low is €6.88.
When is next earnings date of Sesen Bio Inc(FRA:PCBK)?
The next earnings date of Sesen Bio Inc(FRA:PCBK) is 2025-02-28 Est..
Does Sesen Bio Inc(FRA:PCBK) pay dividends? If so, how much?
Sesen Bio Inc(FRA:PCBK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers